Journey Strategic Wealth’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Journey Strategic Wealth's PFE Position: Q1 2026 in Review
Journey Strategic Wealth increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $157K and bringing the position to 57,557 shares worth $1.62M. The position accounts for 0.04% of the portfolio, ranked #128.
Journey Strategic Wealth first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Journey Strategic Wealth held 57,557 shares of Pfizer worth $1.62M as of Q1 2026.
- Journey Strategic Wealth bought 5,905 Pfizer shares in Q1 2026, an estimated $157K.
- Pfizer made up 0.04% of Journey Strategic Wealth's portfolio in Q1 2026, its #128 holding.
- Journey Strategic Wealth first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.